|Systematic (IUPAC) name|
|CAS Registry Number|
|Molecular mass||191.29 g/mol|
|(what is this?)|
Dimethylphenylpiperazinium (DMPP) is a nicotinic acetylcholine receptor agonist which is selective for the ganglionic subtype. One of the earliest reports on the pharmacology of DMPP, describing it as a ganglion-stimulating, hypertensive agent, came from Graham Chen and his co-workers at Parke, Davis & Co.
- Prado WA, Segalla DK (August 2004). "Antinociceptive effects of bethanechol or dimethylphenylpiperazinium in models of phasic or incisional pain in rats". Brain Res. 1018 (2): 272–82. doi:10.1016/j.brainres.2004.05.085. PMID 15276888.
- G. Chen, R. Portman and A. Wickel (1951) J. Pharmacol. Exp. Ther. 103 (1951).
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|